Cholesterol plays a role as the negative regulator for SREBP2 and the mevalonate pathway, but SOAT1-mediated conversion of cholesterol into CEs abrogates the cholesterol feedback mechanism that promotes mevalonate pathway dependency in pancreatic cancer [62]. The gene discussed is SOAT1; the disease is familial pancreatic carcinoma.